Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.
Saved in:
| Title: | Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis. |
|---|---|
| Authors: | Burré J; Appel Institute for Alzheimer's Disease Research and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA., Edwards RH; Department of Physiology and Neurology, University of California, San Francisco School of Medicine, San Francisco, California, USA., Halliday G; Brain and Mind Centre, School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Lang AE; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Lashuel HA; Laboratory of Chemical Biology of Neurodegeneration, Brain Mind Institute, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Melki R; Institut Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Fontenay-Aux-Roses, France., Murayama S; Department of Neuropathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.; The Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka, Japan., Outeiro TF; Department of Experimental Neurodegeneration, University Medical Center, Göttingen, Germany.; Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Papa SM; Department of Neurology, School of Medicine, and Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA., Stefanis L; First Department of Neurology, Eginitio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Woerman AL; Department of Biology, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, Colorado, USA., Surmeier DJ; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA., Kalia LV; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Takahashi R; Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. |
| Corporate Authors: | MDS Scientific Issues Committee |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Oct; Vol. 39 (10), pp. 1663-1678. Date of Electronic Publication: 2024 Jun 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38946200 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burré+J%22">Burré J</searchLink>; Appel Institute for Alzheimer's Disease Research and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+RH%22">Edwards RH</searchLink>; Department of Physiology and Neurology, University of California, San Francisco School of Medicine, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Halliday+G%22">Halliday G</searchLink>; Brain and Mind Centre, School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Lang+AE%22">Lang AE</searchLink>; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lashuel+HA%22">Lashuel HA</searchLink>; Laboratory of Chemical Biology of Neurodegeneration, Brain Mind Institute, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Melki+R%22">Melki R</searchLink>; Institut Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Fontenay-Aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Murayama+S%22">Murayama S</searchLink>; Department of Neuropathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.; The Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Outeiro+TF%22">Outeiro TF</searchLink>; Department of Experimental Neurodegeneration, University Medical Center, Göttingen, Germany.; Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Papa+SM%22">Papa SM</searchLink>; Department of Neurology, School of Medicine, and Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Stefanis+L%22">Stefanis L</searchLink>; First Department of Neurology, Eginitio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Biomedical Research Foundation of the Academy of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Woerman+AL%22">Woerman AL</searchLink>; Department of Biology, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Surmeier+DJ%22">Surmeier DJ</searchLink>; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kalia+LV%22">Kalia LV</searchLink>; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Takahashi+R%22">Takahashi R</searchLink>; Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22MDS+Scientific+Issues+Committee%22">MDS Scientific Issues Committee</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228610688%22">Movement disorders : official journal of the Movement Disorder Society</searchLink> [Mov Disord] 2024 Oct; Vol. 39 (10), pp. 1663-1678. <i>Date of Electronic Publication: </i>2024 Jun 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8610688 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-8257 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208853185%22">08853185 </searchLink><i>NLM ISO Abbreviation: </i>Mov Disord <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38946200 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/mds.29897 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1663 Titles: – TitleFull: Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burré J – PersonEntity: Name: NameFull: Edwards RH – PersonEntity: Name: NameFull: Halliday G – PersonEntity: Name: NameFull: Lang AE – PersonEntity: Name: NameFull: Lashuel HA – PersonEntity: Name: NameFull: Melki R – PersonEntity: Name: NameFull: Murayama S – PersonEntity: Name: NameFull: Outeiro TF – PersonEntity: Name: NameFull: Papa SM – PersonEntity: Name: NameFull: Stefanis L – PersonEntity: Name: NameFull: Woerman AL – PersonEntity: Name: NameFull: Surmeier DJ – PersonEntity: Name: NameFull: Kalia LV – PersonEntity: Name: NameFull: Takahashi R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1531-8257 Numbering: – Type: volume Value: 39 – Type: issue Value: 10 Titles: – TitleFull: Movement disorders : official journal of the Movement Disorder Society Type: main |
| ResultId | 1 |